Article (Scientific journals)
Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.
Moallemian, Soodeh; Salmon, Eric; Bahri, Mohamed Ali et al.
2023In Neurobiology of Aging, 132, p. 24 - 35
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S0197458023002002-main.pdf
Publisher postprint (6.32 MB) Creative Commons License - Attribution, Non-Commercial, No Derivative
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Alzheimer’s disease; MTsat; Multivariate analysis; PET; Quantitative MRI; R2*; Total volume distribution; Iron; Male; Humans; Brain/diagnostic imaging; Brain/pathology; Magnetic Resonance Imaging/methods; Multimodal Imaging/methods; Atrophy/pathology; Alzheimer Disease/diagnostic imaging; Alzheimer Disease/pathology; Demyelinating Diseases; Atrophy; Brain; Magnetic Resonance Imaging; Multimodal Imaging; Neuroscience (all); Aging; Neurology (clinical); Developmental Biology; Geriatrics and Gerontology; General Neuroscience
Abstract :
[en] Multiple neuropathological events are involved in Alzheimer's disease (AD). The current study investigated the concurrence of neurodegeneration, increased iron content, atrophy, and demyelination in AD. Quantitative multiparameter magnetic resonance imaging (MRI) maps providing neuroimaging biomarkers for myelination and iron content along with synaptic density measurements using [18F] UCB-H PET were acquired in 24 AD and 19 Healthy controls (19 males). The whole brain voxel-wise group comparison revealed demyelination in the right hippocampus, while no significant iron content difference was detected. Bilateral atrophy and synaptic density loss were observed in the hippocampus and amygdala. The multivariate GLM (mGLM) analysis shows a bilateral difference in the hippocampus and amygdala, right pallidum, left fusiform and temporal lobe suggesting that these regions are the most affected despite the diverse differences in brain tissue properties in AD. Demyelination was identified as the most affecting factor in the observed differences. Here, the mGLM is introduced as an alternative for multiple comparisons between different modalities, reducing the risk of false positives while informing about the co-occurrence of neuropathological processes in AD.
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
Moallemian, Soodeh  ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Salmon, Eric  ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Bahri, Mohamed Ali  ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Beliy, Nikita  ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Delhaye, Emma  ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Balteau, Evelyne ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Neuroimaging, data acquisition and processing
Degueldre, Christian ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
Phillips, Christophe   ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Neuroimaging, data acquisition and processing
Bastin, Christine   ;  Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory
 These authors have contributed equally to this work.
Language :
English
Title :
Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.
Publication date :
December 2023
Journal title :
Neurobiology of Aging
ISSN :
0197-4580
eISSN :
1558-1497
Publisher :
Elsevier Inc., United States
Volume :
132
Pages :
24 - 35
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
Funding: This work was supported by the ULiege Research Concerted Action (SLEEPDEM, grant 17/2109 ) and Walloon Region in the framework of the PIT program PROTHER-WAL under grant agreement No. 7289. [18F]flutemetamol was provided by GE Healthcare. CB is a Senior Research Associate at the F.R.S.-FNRS and CP is a Research Director at the F.R.S.-FNRS.Funding: This work was supported by the ULiege Research Concerted Action (SLEEPDEM, grant 17/2109) and Walloon Region in the framework of the PIT program PROTHER-WAL under grant agreement No. 7289. [18F]flutemetamol was provided by GE Healthcare. CB is a Senior Research Associate at the F.R.S.-FNRS and CP is a Research Director at the F.R.S.-FNRS.
Available on ORBi :
since 22 January 2024

Statistics


Number of views
32 (5 by ULiège)
Number of downloads
9 (0 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi